Stockreport

4DMT to Participate in Upcoming Investor Meetings

4D Molecular Therapeutics, Inc.  (FDMT) 
PDF EMERYVILLE, Calif., March 16, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advanc [Read more]